医学
转甲状腺素
病因学
淀粉样蛋白(真菌学)
淀粉样变性
淀粉样疾病
病理
血清淀粉样蛋白A
肾
血清淀粉样蛋白A
疾病
淀粉样纤维
免疫学
内科学
炎症
淀粉样β
作者
Nelson Leung,Samih H. Nasr
标识
DOI:10.1053/j.ajkd.2024.01.530
摘要
Amyloidosis is a protein folding disease that causes organ injuries and even death. In humans, 42 proteins are now known to cause amyloidosis. Some proteins become amyloidogenic as a result of a pathogenic variant as seen in hereditary amyloidoses. In acquired forms of amyloidosis, the proteins form amyloid in their wild-type state. Four types (serum amyloid A (AA), transthyretin (ATTR), apolipoprotein AIV (ApoAIV), and beta-2-macroglobulin (AB2m)) of amyloid can occur either as acquired or as a mutant. Iatrogenic amyloid from injected protein medications have also been reported and AIL1RAP (anakinra) has been recently found to involve the kidney. Finally, the mechanism of how leukocyte cell derived chemotaxin-2 (ALECT2) forms amyloid remains unknown. This paper will review amyloids that involve the kidney and how they are typed.
科研通智能强力驱动
Strongly Powered by AbleSci AI